Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

BACKGROUND: PD-1 blocking agents, such as nivolumab, have demonstrated clear anti-tumor effects and clinical benefits in a subset of patients with advanced malignancies. Nonetheless, more efforts are needed to identify reliable biomarkers for outcome, to correctly select patients who will benefit fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Capone, Mariaelena, Fratangelo, Federica, Giannarelli, Diana, Sorrentino, Claudia, Turiello, Roberta, Zanotta, Serena, Galati, Domenico, Madonna, Gabriele, Tuffanelli, Marilena, Scarpato, Luigi, Grimaldi, Antonio M., Esposito, Assunta, Azzaro, Rosa, Pinto, Antonio, Cavalcanti, Ernesta, Pinto, Aldo, Morello, Silvana, Ascierto, Paolo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065327/
https://www.ncbi.nlm.nih.gov/pubmed/32160899
http://dx.doi.org/10.1186/s12967-020-02285-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065327/
https://www.ncbi.nlm.nih.gov/pubmed/32160899
http://dx.doi.org/10.1186/s12967-020-02285-0

Ejemplares similares